GE buys interest in DNA

Share this article:

General Electric has scooped up Thermo Fischer Scientific's DNA purifying and cell-line growing technology for just over $1 billion, Bloomberg reports.

The deal helps both companies pursue their respective business objectives. Bloomberg notes that the deal means GE will now be able to promote technologies that aid discovery and manufacturing of medicines and diagnostics, somewhat counterbalancing its exit from consumer finance.

At the same time, Bloomberg notes, the divestiture could help Thermo Fischer get EU approval to acquire Life Technologies Corp. for $13.6 billion. This deal would put Life's genetic testing and mapping equipment under Thermo's roof.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters